Mesoblast Limited (MEOBF)
OTCMKTS · Delayed Price · Currency is USD
1.590
-0.310 (-16.32%)
At close: Jan 14, 2026
Mesoblast Market Cap
Mesoblast has a market cap or net worth of $2.36 billion as of February 12, 2026. Its market cap has decreased by -2.54% in one year.
Market Cap
2.36B
Enterprise Value
2.32B
Revenue
17.20M
Ranking
n/a
PE Ratio
n/a
Stock Price
$1.59
Market Cap Chart
Since December 16, 2004, Mesoblast's market cap has increased from 57.91M to 2.36B, an increase of 3,977.51%. That is a compound annual growth rate of 19.14%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Feb 11, 2026 | 2.36B | 1.44% |
| Dec 31, 2025 | 2.33B | 5.85% |
| Dec 31, 2024 | 2.20B | 925.48% |
| Dec 29, 2023 | 214.44M | -50.76% |
| Dec 30, 2022 | 435.55M | -34.45% |
| Dec 31, 2021 | 664.44M | -34.77% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Northwest Biotherapeutics | 406.62M |
| CytoDyn | 317.38M |
| Silence Therapeutics | 224.36M |
| Vaxart | 145.67M |
| HST Global | 139.70M |
| BioStem Technologies | 104.83M |
| Nuo Therapeutics | 80.63M |
| VitaSpring Biomedical | 51.78M |